Alec Stranahan
Stock Analyst at B of A Securities
(0.77)
# 2084
Out of 5,255 analysts
31
Total ratings
29.41%
Success rate
13.86%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BEAM Beam Therapeutics | Upgrades: Buy | 42 42 | 19.54 | 114.94% | 1 | Mar 28, 2025 | |
YMAB Y-mAbs Therapeutics | Maintains: Neutral | 14 12 | 4.09 | 193.4% | 5 | Mar 5, 2025 | |
CADL Candel Therapeutics | Initiates Coverage On: Buy | 15 | 4.96 | 202.42% | 1 | Feb 7, 2025 | |
DAWN Day One Biopharmaceu... | Maintains: Buy | 28 25 | 7.74 | 223% | 4 | Jan 7, 2025 | |
CRBU Caribou Biosciences | Maintains: Buy | 13 11 | 0.77 | 1328.57% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 5 5 | 1.39 | 259.71% | 2 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 24 6 | 2.37 | 153.16% | 2 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 48 55 | 38.82 | 41.68% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 12 18 | 6.63 | 171.49% | 3 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 118 140 | 168.4 | -16.86% | 3 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 42 | 10.49 | 300.38% | 1 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 5 6 | 41.35 | -85.49% | 2 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 60 5 | 0.85 | 488.24% | 1 | Dec 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 45 | 44.73 | 0.6% | 1 | Dec 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 58 | n/a | n/a | 1 | May 20, 2022 |